Results
| PMID | 19407222 |
| Gene Name | PTGER4 |
| Condition | Endometriosis |
| Association |
Associated |
| Sex | Female |
| Associated genes | PTGER2, PTGER4 |
| Other associated phenotypes |
Endometriosis |
|
Mol Endocrinol. 2009 Aug;23(8):1291-305. doi: 10.1210/me.2009-0017. Epub 2009 Apr Banu, Sakhila K| Lee, JeHoon| Speights, V O Jr| Starzinski-Powitz, Anna| Arosh, Joe A Reproductive Endocrinology and Cell Signaling Laboratory, Department of Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas 77843, USA. Endometriosis is a benign chronic gynecological disease of reproductive-age women characterized by the presence of functional endometrial tissues outside the uterine cavity. It is an estrogen-dependent disease. Current treatment modalities to inhibit biosynthesis and actions of estrogen compromise menstruation, pregnancy, and the reproductive health of women and fail to prevent reoccurrence of disease. There is a critical need to identify new specific signaling modules for non-estrogen-targeted therapies for endometriosis. In our previous study, we reported that selective inhibition of cyclooxygenase-2 prevented survival, migration, and invasion of human endometriotic epithelial and stromal cells, which was due to decreased prostaglandin E(2) (PGE(2)) production. In this study, we determined mechanisms through which PGE(2) promoted survival of human endometriotic cells. Results of the present study indicate that 1) PGE(2) promotes survival of human endometriotic cells through EP2 and EP4 receptors by activating ERK1/2, AKT, nuclear factor-kappaB, and beta-catenin signaling pathways; 2) selective inhibition of EP2 and EP4 suppresses these cell survival pathways and augments interactions between proapoptotic proteins (Bax and Bad) and antiapoptotic proteins (Bcl-2/Bcl-XL), facilitates the release of cytochrome c, and thus activates caspase-3/poly (ADP-ribose) polymerase-mediated intrinsic apoptotic pathways; and 3) these PGE(2) signaling components are more abundantly expressed in ectopic endometriosis tissues compared with eutopic endometrial tissues during the menstrual cycle in women. These novel findings may provide an important molecular framework for further evaluation of selective inhibition of EP2 and EP4 as potential therapy, including nonestrogen target, to expand the spectrum of currently available treatment options for endometriosis in women. Mesh Terms: *Apoptosis| Endometriosis/metabolism/pathology| Endometrium/*metabolism/pathology| Female| Humans| Microscopy, Fluorescence/methods| Mitochondria/pathology| Mitogen-Activated Protein Kinase 1/*metabolism| Mitogen-Activated Protein Kinase 3/*metabo |
|